Ishita Drugs and Industries Limited (BOM:524400)
67.60
-4.30 (-5.98%)
At close: Mar 6, 2026
BOM:524400 Market Cap
BOM:524400 has a market cap or net worth of 202.14 million as of March 6, 2026. Its market cap has decreased by -17.50% in one year.
Market Cap
202.14M
Enterprise Value
115.17M
Revenue
161.68M
Ranking
n/a
PE Ratio
22.76
Stock Price
67.60
Market Cap Chart
Since May 24, 2005, BOM:524400's market cap has increased from 25.69M to 202.14M, an increase of 686.96%. That is a compound annual growth rate of 10.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 202.14M | -15.50% |
| Dec 31, 2025 | 239.22M | -13.45% |
| Dec 31, 2024 | 276.39M | 28.48% |
| Dec 29, 2023 | 215.12M | 39.01% |
| Dec 30, 2022 | 154.75M | 11.89% |
| Dec 31, 2021 | 138.30M | 41.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Accretion Nutraveda | 1.31B |
| Krebs Biochemicals & Industries | 1.20B |
| Resonance Specialties | 1.13B |
| Tyche Industries | 1.12B |
| Bacil Pharma | 716.93M |
| Vasundhara Rasayans | 381.38M |
| Crestchem | 267.81M |
| Venmax Drugs and Pharmaceuticals | 185.06M |